Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical ...
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, ...
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why
Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock skyrocketed with a strong session volume of 201.04 million, compared to the ...
Targeted Oncology12 天
FDA Clears Novel Cancer Immunotherapy R-5780 for Early-Stage Trial
R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...
Pharmabiz1 天
Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with ...
Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer: United States Saturday, January ...
The American Journal of Managed Care6 天
Combination Immunotherapy Offers New Pathway for Skin Cancer Prevention
A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...
来自MSN11 个月
Cancer stages, survival rates and what a diagnosis really means
The Palace has already announced that King Charles does not have prostate cancer. Take, for example, lung cancer. The most common forms of lung cancer are squamous cell carcinoma, adenocarcinoma ...
Medscape13 天
NECTORS for Advanced HPV-Related Head and Neck Cancer?
Neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to better survival outcomes ...